Shares of Profusa (PFSA) hit a record low on Thursday, crashing 28% after the biotech company announced its second reverse ...

That is a big risk investors take when trying to find the winners and losers within the biotech sector. While we made the ...

We recently compiled a list of the 10 Most Promising Cancer Stocks According to Wall Street Analysts. Syndax Pharmaceuticals, ...

Morgan Stanley says U.S. equity-market leadership is beginning to expand beyond the semiconductor and AI infrastructure ...

Candel Therapeutics (CADL) shifts to late-stage oncology with CAN-2409 Phase III wins and BLA catalyst. Read here for a ...

Viking Therapeutics (NASDAQ: VKTX) is one of the hopefuls in a very exciting pharmaceutical and biotech space right now: the ...

Customs Department has initiated probe against its general manager, sales and marketing officer Sreekant Sreedharan of ...

Morgan Stanley’s pivot is from “chip winners” to hyperscalers with AI infrastructure optionality. MSFT has the strongest mix ...

One company leads in gene-editing approvals, while the other targets surging demand in metabolic treatments. Here’s how their financials and risk profiles compare.

We recently compiled a list of the 10 Best Biotech Stocks to Buy According to Analysts. Jade Biosciences, Inc. (NASDAQ:JBIO) ...

China and Hong Kong stocks rose on Monday as signs emerged that investor enthusiasm for artificial intelligence was ...

TheFly reported on June 24 that Raymond James initiated coverage of MPLT with a Strong Buy rating and a $46 price target.